Role of protein S in castration-resistant prostate cancer-like cells.
暂无分享,去创建一个
[1] H. Miyake,et al. Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration-resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo. , 2015, Urology.
[2] M. Gleave,et al. Targeting the adaptive molecular landscape of castration-resistant prostate cancer , 2015, EMBO molecular medicine.
[3] W. Figg,et al. Beyond PSA: managing modern therapeutic options in metastatic castration-resistant prostate cancer. , 2015, Southern medical journal.
[4] M. Gleave,et al. Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer , 2015, Oncotarget.
[5] H. Moch,et al. Molecular foundations for personalized therapy in prostate cancer. , 2015, Current drug targets.
[6] Zhe Zhang,et al. Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer. , 2014, Cancer research.
[7] Wei Li,et al. A chromatin modifier regulates Sertoli cell response to mono-(2-ethylhexyl) phthalate (MEHP) via tissue inhibitor of metalloproteinase 2 (TIMP2) signaling. , 2014, Biochimica et biophysica acta.
[8] Yong Li,et al. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways , 2014, Cell Death and Disease.
[9] Ronald C. Chen,et al. Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Zoubeidi,et al. Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer , 2014, Oncogenesis.
[11] L. Adams,et al. New recommendations in prostate cancer screening and treatment , 2014, JAAPA : official journal of the American Academy of Physician Assistants.
[12] E. Antonarakis,et al. Castration-resistant prostate cancer: latest evidence and therapeutic implications , 2014, Therapeutic advances in medical oncology.
[13] O. Sartor,et al. Castration-resistant prostate cancer: adaptive responses in the androgen axis. , 2014, Cancer treatment reviews.
[14] E. Lasorsa,et al. Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer , 2013, Oncotarget.
[15] He Wang,et al. Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC‐3 human prostate cancer cells , 2013, FEBS letters.
[16] S. Hotte,et al. Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review. , 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).
[17] Andrew J Armstrong,et al. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. , 2013, Endocrine-related cancer.
[18] G. Espinosa,et al. Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity , 2013, Arthritis Research & Therapy.
[19] S. Nilsson,et al. Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy , 2013, PloS one.
[20] A. Armstrong,et al. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. , 2013, Endocrine-related cancer.
[21] H. Ho,et al. Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress. , 2013, Free radical biology & medicine.
[22] E. Wallen,et al. A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. , 2013, Urologic oncology.
[23] Dominique Trudel,et al. Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer , 2012, The Journal of Biological Chemistry.
[24] Yue Zhang,et al. Toll‐like receptor‐mediated inhibition of Gas6 and ProS expression facilitates inflammatory cytokine production in mouse macrophages , 2012, Immunology.
[25] Cora N. Sternberg,et al. Castration-Resistant Prostate Cancer , 2010, Drugs.
[26] Seiji Naito,et al. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer. , 2011, Free radical biology & medicine.
[27] Bao-xue Yang,et al. Prostate cancer: an emerging threat to the health of aging men in Asia. , 2011, Asian journal of andrology.
[28] H. Kung. Targeting Tyrosine Kinases and Autophagy in Prostate Cancer , 2010, Hormones & cancer.
[29] José A Fernández,et al. Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway , 2011, Molecular Neurodegeneration.
[30] Ayako Nishimoto,et al. Establishment and characterization of an androgen receptor‐dependent, androgen‐independent human prostate cancer cell line, LNCaP‐CS10 , 2010, The Prostate.
[31] Su Qu,et al. PI3K-AKT-mTOR Pathway is Dominant over Androgen Receptor Signaling in Prostate Cancer Cells , 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[32] José A Fernández,et al. Species-specific anticoagulant and mitogenic activities of murine protein S , 2009, Haematologica.
[33] G. Lemke,et al. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. , 2009, The Journal of clinical investigation.
[34] Jie Zhao,et al. Involvement of Metastasis Tumor Antigen 1 in Hepatic Regeneration and Proliferation , 2008, Cellular Physiology and Biochemistry.
[35] Wei Li,et al. Metastasis tumor antigen 1 is involved in the resistance to heat stress‐induced testicular apoptosis , 2008, FEBS letters.
[36] B. Dahlbäck. The tale of protein S and C4b-binding protein, a story of affection , 2007, Thrombosis and Haemostasis.
[37] N. Caplen,et al. Defining and assaying RNAi in mammalian cells. , 2005, Molecular cell.
[38] M. Thakur,et al. Androgen receptor mRNA is inversely regulated by testosterone and estradiol in adult mouse brain , 2004, Neurobiology of Aging.
[39] D. Grigoryev,et al. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. , 2000, Cancer research.